Pros and cons of a prion-like pathogenesis in Parkinson's disease.

MLA

Hilker, Ruediger, et al. “Pros and Cons of a Prion-like Pathogenesis in Parkinson’s Disease.” BMC Neurology, vol. 11, no. 1, Jan. 2011, pp. 74–78. EBSCOhost, https://doi.org/10.1186/1471-2377-11-74.

APA

Hilker, R., Brotchie, J. M., & Chapman, J. (2011). Pros and cons of a prion-like pathogenesis in Parkinson’s disease. BMC Neurology, 11(1), 74–78. https://doi.org/10.1186/1471-2377-11-74

Chicago

Hilker, Ruediger, Jonathan M. Brotchie, and Joab Chapman. 2011. “Pros and Cons of a Prion-like Pathogenesis in Parkinson’s Disease.” BMC Neurology 11 (1): 74–78. doi:10.1186/1471-2377-11-74.